← Eichor
Condition: Inherited Movement Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Inherited Movement Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Spanish Wilson Disease Registry
Phase N/A · 1 location(s) · Asociación Española para el Estudio del Hígado · NCT06466291
Hinting Task for Huntington's Disease
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT06774443
Multitarget Stereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome
NA · 1 location(s) · Beijing Tiantan Hospital · NCT06889480
Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics
NA · 1 location(s) · University of Utah · NCT06825520
NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT04851678
Molecular and Functional Imaging in Monogenic PD.
Phase N/A · 1 location(s) · University of Exeter · NCT05518617
Phenotype/Genotype Correlations in Movement Disorders
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT00018889
Cardiac Involvement in Wilson's Disease
NA · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT05493605
Effect on Periodontal Phenotype of Flapless Piezoincission During Orthodontic Treatment
NA · 1 location(s) · Universidad Complutense de Madrid · NCT06315348
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Phase 2 · 7 location(s) · Holland Bloorview Kids Rehabilitation Hospital · NCT06081348
A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
Phase 1 · 3 location(s) · Solid Biosciences Inc. · NCT07180355
Angelman Syndrome Natural History Study
Phase N/A · 11 location(s) · Boston Children's Hospital · NCT04507997
Neurosurgical Outcome Network
Phase N/A · 27 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06724029
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Phase N/A · 183 location(s) · CHDI Foundation, Inc. · NCT01574053
Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Com
NA · 2 location(s) · University College London Hospitals · NCT07725926
International Wilson's Disease Patient Registry (iWilson Registry)
Phase N/A · 16 location(s) · Orphalan · NCT05239858
Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome
NA · 1 location(s) · National Taipei University of Nursing and Health Sciences · NCT06613126
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Part
Phase 1/Phase 2 · 11 location(s) · Ionis Pharmaceuticals, Inc. · NCT05127226
Deep Brain Stimulation Therapy in Movement Disorders
NA · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT02119611
Study to Evaluate Music Therapy on Irritability and Impulsivity in Patients With Huntington's Disease (MUSIC-HD)
NA · 1 location(s) · Poitiers University Hospital · NCT06414967
The Global Angelman Syndrome Registry
Phase N/A · 1 location(s) · Foundation for Angelman Syndrome Therapeutics, Australia · NCT05293184
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's
Phase N/A · 40 location(s) · University College, London · NCT02855476
Observational Database on Deep Brain Stimulation in Tourette Syndrome
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04449068
18F-DOPA II - PET Imaging Optimization
Phase 3 · 1 location(s) · University of Alberta · NCT04706910
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Phase 3 · 51 location(s) · Novartis Pharmaceuticals · NCT07326709
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136844
Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease
NA · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT07513844
Gene Therapy Development and Validation for Huntington's Disease Fibro TG-HD
NA · 1 location(s) · University Hospital, Angers · NCT06444217
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.